naltrexone with semaglutide and tirzepatide RETRACTED ARTICLE: Effect of combined GLP-1 analogue bupropion/ on weight loss: a retrospective cohort study Obesity drugs under review: Semaglutide, – Low-Dose Naltrexone for Weight Loss:

Immunofluorescence showed that Ac-KGHK significantly stimulated the production of collagen III and laminin in human fibroblasts (MRC5)

For mild-to-moderate Alzheimers, a 2015 meta-analysis pooled six randomized trials and reported small positive effects (Gauthier et al., 2015, pooled RCTs)

Abbreviations CKD: Chronic kidney disease DKA: Diabetic ketoacidosis FDA: US Food and Drug Administration GLP-1 RA: Glucagon-like peptide-1 receptor agonist HCO: Healthcare organisation IHD: Ischaemic heart disease PSM: Propensity score matching SGLT2i: Sodium-glucose cotransporter 2 inhibitor SSMD: Strictly standardised mean difference UTI: Urinary tract infection References Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study

Patel is dedicated to optimizing health outcomes and delivering the highest standard of pharmaceutical care